02/18/2022 Edition 52
----- Division of Research -----
COVID-19
National Institute of Mental Health (NIMH)

Deadline: January 7, 2025
NIMH is especially interested in research to provide an evidence base to understand how mental illness contributes to COVID-19 risk and mortality, how incident mental illness develops with COVID-19, and the development of scalable interventions to meet the public mental health needs during and resulting from the pandemic both specifically related to the virus but also at a broader population level that is impacted by stress, disruptions, and loss of lives in the pandemic. Research addressing the intersection of COVID-19, mental health, and HIV treatment and prevention are also of interest to NIMH. Research is anticipated to focus on particularly vulnerable populations based on existing evidence of increased mental health symptoms and illness and preexisting and worsening health disparities.
National Eye Institute (NEI)

Deadline: March 9, 2024
NOSI to support research addressing the urgent need to provide accessible home-based COVID testing to people who are visually impaired.

This NOSI encourages researchers to leverage existing partnerships and build new partnerships with key stakeholders to develop and implement specific, targeted approaches for home-based testing strategies for people with visual impairment. Strategies should be scalable, sustainable, and consider the multiple stakeholders (e.g., visually impaired, blind children, adults with low vision, older adults, parents/guardians, caregivers).
National Heart, Lung, and Blood Institute (NHLBI)

Deadline: July 05, 2025
This NOSI aims to accelerate a comprehensive understanding of the mechanisms of COVID-19-Associated Coagulopathy (CAC) which are provoked by vascular endothelial cell injury, hyperimmune responses, and hypercoagulability at genomic, molecular, and cellular levels.

This NOSI will support research that focuses on the basic mechanisms of COVID-19 associated thrombosis ranging from vascular endothelial cell injury, the host immune responses, to the coagulation and fibrinolysis systems. Identifying risk factors, or co-morbidities that predispose patients to CAC is also of interest.
Environmental Health Sciences
National Institute of Environmental Health Sciences (NIEHS)

Deadline: June 09, 2022
The NIEHS Revolutionizing Innovative, Visionary Environmental health Research (RIVER) program is intended to provide support for outstanding investigators in the Environmental Health Sciences, giving them intellectual and administrative freedom, as well as sustained support to pursue their research in novel directions in order to achieve greater impacts. The program seeks to identify individuals with a potential for continued innovative and impactful research and combine their existing investigator-initiated research into a single award to support the majority of their independent environmental health sciences research program.
Career Enhancement
National Institutes of Health (NIH)

Deadline: March 15, 2022, August 1, 2022, May 1, 2023
This Funding Opportunity Announcement (FOA) invites applications from early and mid-career investigators (i.e. postdoctoral fellow/associates – associate professor) who strive to expand their research trajectories through the acquisition of new knowledge and skills in the areas of therapeutic drug, biologic, or device development. The development of novel treatments for pain, addiction, and overdose is a vital component to address the ongoing opioid epidemic. This development will be most effective if performed by scientists with experience in translational science.
Federal
View current federal funding opportunities (pdf) 02/11/2022 curated by our Van Scoyoc partnership.
Foundation
The Office of Sponsored Programs will be the submitting authorized official for these announcements. We strongly encourage Principal Investigators to utilize the UNLV Corporate & Foundation Relations assistance with the preparation of any narrative portions of the proposal(s). 
Paul G. Allen Frontiers Group Invites LOIs for 2022 Allen Distinguished Investigators - Up to $1,250,000 over three years to support technology development in two tracks: Protein Lifespan and Nutrient Sensing. Letters of Intent due March 1, 2022
Lupus Research Alliance Invites Applications for Innovation Award - $150,000 per year for up to two years in support of pioneering, high-risk, high-reward approaches to major challenges in lupus research. Letters of Intent due March 1, 2022
Althea Sheets, Communications Manager for Research Development, Office of Sponsored Programs, [email protected], 702-895-1880